Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2941-2951
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2941
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2941
Variable | Local tumor pregression | |||
Univariate analysis | Multivariate analysis | |||
HR (95%CI) | P value | HR (95%CI) | P value | |
Female sex | 0 (0-Inf) | 0.086 | ND | ND |
Age | 1.02 (0.96-1.09) | 0.487 | ND | ND |
Etiology | 0.407 | ND | ND | |
HCV | Reference | ND | ND | |
HBV | 1.31 (0.17-10.11) | ND | ND | |
Non-viral | 0 (0-Inf) | ND | ND | |
CP B | 0.66 (0.08-5.08) | 0.668 | ND | ND |
AFP ≥ 200 ng/mL | 2.07 (0.45-9.46) | 0.388 | ND | ND |
PLT | 1.0031 (0.9966-1.0096) | 0.381 | ND | ND |
Non-undergone hepatectomy | 0.46 (0.10-2.08) | 0.271 | ND | ND |
Amount of iodized oil in mL | 1.34 (1.15-1.57) | 0.001 | 1.52 (1.11-2.08) | 0.009 |
Amount of epirubicin in mg | 1.07 (0.96-1.19) | 0.174 | ND | ND |
Tumor number of 2 | 3.23 (0.70-14.80) | 0.186 | 13.22 (1.62-107.51) | 0.016 |
Tumor size in cm | 2.59 (1.48-4.52) | < 0.001 | ND | ND |
Transpulmanory: 1 vs 0 | 1.50 (0.48-4.72) | 0.487 | ND | ND |
Nonsubphrenic vs subphrenic | 1.29 (0.42-4.00) | 0.661 | ND | ND |
- Citation: Zhu ZY, Qian Z, Qin ZQ, Xie B, Wei JZ, Yang PP, Yuan M. Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation. World J Gastrointest Oncol 2024; 16(7): 2941-2951
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2941.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.2941